 Table of 
SI-1.3 Construction and integration of gene expression cassettes for in vivo studies
Fungal genes used for in vivo expression were predicted from the genomic DNA cluster of 3 , except for the easF from Aspergillus fumigatus which was based on public sequence information (GenBank:XM_751050). Genes were synthesized, with yeast codon optimization, by DNA2.0 Inc., Menlo Park, CA, USA or GeneArt AG, Regensburg, Germany. The S. cerevisiae genes pdi1 and fad1 were amplified by PCR directly from genomic DNA.
Aspergillus japonicus
For expression, all genes were cloned into expression vectors based on pRS313, pRS314, pRS315, and pRS316 4, 5 . These vectors were provided with expression cassettes, comprising promoters and terminators amplified by PCR from yeast genomic DNA as previously described 5 . Five expression cassettes containing 1) a GPD1 promoter and a CYC1 terminator (G/C), 2) a PGK1 promoter and an ADH2 terminator (P/A), 3) a PDC1
promoter and an FBA1 terminator (P/F), 4) a TEF1 promoter and an ENO2 terminator (T/E), and 5) a TEF2 promoter and a PGI1 terminator (T/P) were constructed in the pRS vectors.
Integration vectors were constructed, based on these expression cassettes, as previously described for YORWΔ22 5, 6 . Four additional constructs were made based on the integration sites YHRCΔ14, YMRWΔ15, YNRCΔ9, andYPRC τ3, described by Flagfeldt et al. 6 , and each construct was equipped with 3-5 expression cassettes.
The yeast strain used for cycloclavine 6 production was the Saccharomyces cerevisiae S288c, Mat α, NCYC3608, obtained from the National Collection of Yeast Cultures, Norwich, U.K. This basic strain has the KanMX antibiotic marker inserted into the Ura3 locus, and a non-functional HO locus 7 . This strain was subjected to 5 rounds of transformation, integrating a total of 21 gene expression cassettes (excluding markers) into the yeast genome to yield the cycloclavine producing strain (Table S1 ).
SI-1.4 Shake flask culture conditions
Engineered yeast strains were grown in standard SC broth with 2% glucose, minus relevant amino acids (ForMedium, Hunstanton, U.K.). Cultures for analysis were started from re-streaked, single colonies. These were grown overnight in standard SC broth, and then diluted to an optical density, at 600 nm, of 0.1 to start the main culture. Unless otherwise stated, main cultures were grown at 20°C with constant shaking at 150 rpm, 5 cm amplitude, for 72 hours in 250 mL shake flasks containing 25 mL medium.
SI-1.5 Fed-batch fermentation conditions
Production of cycloclavine 6 and festuclavine 4 in yeast appeared to be coupled to biomass production, and hence the fermentation process was a fed-batch that aimed to produce high biomass. Therefore, a conventional feeding regime was chosen and aeration and stirring regimes were aimed to avoid fermentative metabolism and minimize glucose accumulation as well as ethanol-and acetate formation.
The process was started as a batch using synthetic complete medium (SC), after which a feed was started that contained glucose, salts, vitamins, trace metals and amino acids. Table S4 .
For inoculation of the fermenter a 1-stage seed train was used. Seed cultures were prepared by inoculating 50 mL of medium in a 500-ml shake flask with 4 baffles (indents) to a starting OD 600 of ca. 0.4, using freshly grown colonies from an YPD plate. The seed medium consisted of SC-medium with 20 g/L glucose (Table S5 ). The shake flasks were placed on a shaking table with amplitude of 25 mm at 250 rpm at 20 ºC. The cells were grown into exponential phase until, after ~23 h., the OD 600 was ca. 3 (CDW ca. 0.9 g/L).
Prior to inoculation, an amount of the batch-medium in the fermenter equivalent to the amount of inoculum was removed and an aliquot of 10 mL of the seed culture was used for (Table S5 ).
After ca. 40 hours, a feed was started that contained a mixture of glucose, vitamins, tracemetals and salts, and was furthermore enriched with amino acids (Table S6 ). During said feeding phase, ammonium hydroxide (5M NH 4 OH) was used both as the nitrogen source and the base to control pH. Tables S7 and S8 list the compositions of the stock solutions of trace metals and vitamins, respectively.
The estimated total addition of feed was ca. 68 mL in 120 hours, according to a feed regime consisting of i) an exponential feeding phase of 30 hours, during which ca. 16 mL of feed were added, followed by ii) a second exponential feeding phase also of 30 hours during which ca. 15 mL of feed were added, and iii) a final constant feeding phase of 60 hours during which ca. 37 mL of feed were added.
SI-1.6 Cloning, overexpression, and purification of Aspergillus japonicus EasD, EasA, EasG and EasH for in vitro studies
The coding sequences (CDS) of EasD, EasA, EasG, and EasH were predicted from the genome sequence, using free on-line prediction tools, and synthesized with yeast codon optimization. The genes were cloned into plasmids pRS pRS313-316, which had been equipped with yeast promoters and terminators (see above). These vectors carry different auxotrophic markers allowing simultaneous expression in the yeast cell.
For heterologous protein expression, easA was amplified using the following primer pair:
forward primer 5'-GATTCATATGACCATCGATCCATCT-3' (NdeI site underlined); reverse and cloned into pEVE1914. This yeast expression vector provided an N-terminal FLAG-tag for protein purification, and allowed expression of the fusion protein from a Cup1 promoter.
Expression of EasH was carried out in synthetic complete medium (SC) without uracil.
Saccharomyces cerevisiae InvSci1 cells were grown to an OD 600 of 0.8 (2 days) prior to induction with copper(II) sulfate (300 µM) and grown for 16 hours at 20°C prior to harvesting.
Cells were re-suspended in buffer (50mM K 2 HPO 4 , 100 mM NaCl, 10% (v/v) glycerol, pH = 7.0) and lysed by cell disruptor. Cellular debris was pelleted by centrifugation (23,000 x g for 0.5 hour). Crude EasH enzyme was purified by FLAG-tag purification. The eluted enzyme was then concentrated to approximately 400 µL volume and injected (2 x 200 µL) onto a Superdex 200 10/300 GL column (GE Healthcare) equilibrated with 50 mM phosphate buffer pH 7.0 containing 150 mM NaCl. The gel filtration chromatography was performed on an Akta purifier (GE Healthcare) at 0.6 mL/min using 50 mM phosphate buffer pH 7.0 as mobile phase. Elution was followed at 280 nm and 0.5 mL fractions were collected. The yield of EasH was estimated to be 2 mg per litre of culture as measured by BCA assay. Fractions containing EasH, as demonstrated by SDS-PAGE, were collected and dialyzed against dialysis buffer (50 mM K 2 HPO 4 , 100 mM NaCl, 10% (v/v) glycerol, pH = 7.0) ( Figure S9 ).
SI-1.7 Cloning, overexpression, and purification of Aspergillus fumigatus EasA, EasG
Cloning of easA from A. fumigatus into pET-28a(+) (Novagen) was previously reported 1 .
Expression was carried out in LB media with kanamycin (50 µg/mL). E. coli SlouBL21 cells were grown to an OD 600 of 0.7 prior to induction with IPTG (1 mM) and grown for 16 hours at 15°C prior to harvesting. Cells were re-suspended in buffer (20mM Tris-HCl, 300 mM NaCl, Fig. S9 ).
Cloning of easG from A. fumigatus into pET-24a(+) (Novagen) was previously reported. 8 Expression was carried out in LB medium (supplemented with 1% glucose) with kanamycin (50 µg/mL) and chloramphenicol (34 µg/mL). E. coli Rosetta (DE3) pLysS cells (Invitrogen)
were grown to an OD 600 of 0.8, then transferred to 15°C for 1 h prior to induction with IPTG (1 μM) and grown for 16 hours at 15°C prior to harvesting. After centrifugation at 3500 x g for 15 min, the cells were re-suspended in 50 mM Tris-HCl buffer pH 8.0 containing 50 mM glycine, 500 mM NaCl, 5% (v/v) glycerol, 20 mM imidazole and protease inhibitors (Roche) and lysed by cell disruptor. Cellular debris was pelleted by centrifugation (23,000 x g for 30 min). The supernatant was loaded onto a HisTrap FF 5 mL column at a flow rate of 4 mL/min. The column was then washed at 4 mL/min with buffer A until the absorbance at 280 nm reached the baseline value. EasG was step eluted using 50 mM Tris-HCl buffer pH 8.0 containing 50 mM glycine, 500 mM NaCl, 5% (v/v) glycerol and 500 mM imidazole at 4 mL/min. The eluted enzyme was then concentrated to approximately 400 µL volume and injected (2 x 200 µL) onto a Superdex 200 10/300 GL column (GE Healthcare) equilibrated with 50 mM phosphate buffer pH 7.0 containing 150 mM NaCl. The gel filtration chromatography was performed on an Akta purifier (GE Healthcare) at 0.6 mL/min using 50 mM phosphate buffer pH 7.0 as mobile phase. Elution was followed at 280 nm and 0.5 mL fractions were collected. The overall yield of EasG was estimated to be 1 mg per litre of culture as measured by BCA assay. Fractions containing pure EasG, as demonstrated by SDS-PAGE, were collected and exchanged with dialysis buffer (50 mM K 2 HPO 4 , 100 mM NaCl, 10% (v/v) glycerol, pH = 7.0) ( Figure S9 ).
SI-1.8 In vitro endpoint assays for EasA, EasG and EasH
In vitro assays used EasA, EasG and EasH purified as described above. Proteins were taken as frozen aliquots stored at -80 °C. Enzymes could be stored without detectable loss of activity for at least three months. A standard endpoint assay incubated EasA (0.5 μM, 
SI-1.9 Analytical procedures for in vivo experiments
For analysis, yeast cultures were spun down for 10 min at 1000 × g. The pellet and the supernatant were separated. Without further purification, 5 µl of supernatant were injected in a UPLC-TOF (Waters AcquityTM Ultra Performance LC, Waters, Milford, Mass., USA)
coupled to a micrOTOF-Q II (Bruker Daltonik GmbH, Bremen, Germany). Stationary phase column was an Acquity UPLC® Bridged Ethyl Hybrid (BEH) C18; 1.7 µm; 2.1×100 mm. 
SI-1.11 Mass spectrometry (in vitro assays)
Ultraperformance liquid chromatography was performed on a Waters Acquity UPLC system consisting of a binary pump, an online vacuum degasser, an autosampler, and a column compartment. Separation of the analytes was achieved on a Waters Acquity Ultra
Performance BEH C18 column with 1.7 µm particle size, 2. 
SI-1.12 Nuclear magnetic resonance (NMR) spectroscopy
NMR experiments of cycloclavine 6 and festuclavine 4 were performed respectively in CDCl 3 and DMSO-d 6 at 25ºC using a Bruker Avance III 600MHz NMR spectrometer equipped with a 1.7mm cryogenic TCI probe. The structure of cycloclavine 6 was solved by means 1 H-NMR, 13 C-NMR, 1 H, 1 H-ROESY, and 1 H, 13 C-HMBC. No new products were detected, and none of the two products seem to be a substrate for easG. Expression of easD in combination with easA (ii), both from Aspergillus japonicus, resulted in production of a new compound, with an [M + H] + of 257. This compound was not purified, but is likely to be dihydro-chanoclavine-I aldehyde 7, which was also seen in the in vitro assay ( Figure S21) . Expression of easD (Aspergillus japonicus) in combination with easA and easG from either Aspergillus japonicus (iii) or from Aspergillus fumigatus (iv) resulted in the production of festuclavine 4 ([M + H] + = 241).
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Figure S4
The ratio between cycloclavine 6 and festuclavine 4 production depends on the copy number of easH A yeast strain expressing the entire cycloclavine pathway, comprising a single copy of easH (eash x 1), produced cycloclavine 6 and festuclavine 4 approximately in the ratio 3:2. Addition of 1, 2, or 3 extra gene copies increased this ratio in a dose dependent manner. With 3 additional copies (easH x 4) the ratio was more than 7:1 of cycloclavine 6 to festuclavine 4. Standard curve for cycloclavine 6 concentration and peak area response observed by LC-MS. The concentrations 1.25-0.039 µM represent the full range of cycloclavine 6 product that was analyzed by mass spectrometry.
Figure S12 Time course of EasH assays
Conditions are as described in the methods for in vitro endpoint assays unless otherwise specified. Cycloclavine 6 concentration increases with time.
Figure S13 Concentration of cycloclavine 6 increases with increasing EasH concentration and with time
Conditions are as described in the methods for in vitro endpoint assays unless otherwise specified.
Figure S14 Cycloclavine 6 formation dependence on concentration of chanoclavine-I aldehyde 3 and time Concentration of cycloclavine 6 increases with increasing chanoclavine-I aldehyde 3 concentration and with time. Conditions are as described in the methods for in vitro endpoint assays unless otherwise specified.
Figure S15
The pH optimum of cycloclavine 6 formation by EasA, EasG and EasH (A. japonicus) was determined to be pH = 7 Assay conditions are as described in the methods for in vitro endpoint assays. Buffers used were: 100 mM K 2 HPO 4 buffers at pH: 5, 6, 7 and 8 were used. Figure S18 UV spectra of EasH (a) EasH which contains bound NADP + (after first purification by FLAG-tag); (b) EasH subjected to a second purification step (by gel filtration column), which loses activity in within 48 hours, appears to have lost the NADP + cofactor during the second purification step. Table S6 ) 30 [ml/L] Trace metal stock solution (see Table S7) 15 [ml/L] *Yeast Nitrogen Base 
